To ban or not to ban? Clinical geneticists' views on the regulation of direct-to-consumer genetic testing

EMBO Reports

Volumn 13, Issue 9, 2012, Pages 791-794

  Howard, Heidi Carmen ^a   Borry, Pascal ^a,b  

^a Faculté de Médecine Centre Hospitalo universitaire   (France)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONSUMER; ETHICS; GENETIC RISK; GENETIC SCREENING; HEALTH CARE PERSONNEL; HUMAN; LEGAL ASPECT; PRIORITY JOURNAL;

CONSUMER HEALTH INFORMATION; GENETIC TESTING; HUMANS; PHYSICIANS;

EID: 84865760639     PISSN: 1469221X     EISSN: 14693178     Source Type: Journal    
DOI: 10.1038/embor.2012.114     Document Type: Article

References (23)

1. Kolor K, Liu T, St Pierre J, Khoury MJ (2009) Health care provider and consumer awareness, perceptions, and use of direct-to-consumer personal genomic tests, United States, 2008. Genet Med 11: 595
2. Powell KP, Cogswell WA, Christianson CA, Dave G, Verma A, Eubanks S, Henrich VC (2012) Primary care physicians' awareness, experience and opinions of direct-to-consumer genetic testing. J Genet Couns 21: 113-126
3. Brett GR, Metcalfe SA, Amor DJ, Halliday JL (2012) An exploration of genetic health professionals' experience with direct-to-consumer genetic testing in their clinical practice. Eur J Hum Genet 20: 825-830
4. Giovanni MA, Fickie MR, Lehmann LS, Green RC, Meckley LM, Veenstra D, Murray MF (2010) Health-care referrals from direct-to-consumer genetic testing. Genet Test Mol Biomarkers 14: 817-819
5. Ohata T, Tsuchiya A, Watanabe M, Sumida T, Takada F (2009) Physicians' opinion for 'new' genetic testing in Japan. J Hum Genet 54: 203-208
6. Borry P, van Hellemondt RE, Sprumont D, Jales CF, Rial-Sebbag E, Spranger TM, Curren L, Kaye J, Nys H, Howard H (2012) Legislation on direct-to-consumer genetic testing in seven European countries. Eur J Hum Genet 20: 715-721
7. Rial-Sebbag EB (2012) Direct-to-consumer genetic testing: regulating offer or use? Pers Med 9: 315-317
8. Genetics and Public Policy Center (2007) Survey of Direct-to-Consumer Testing Statutes and Regulations. http://www.dnapolicy.org/resources/ DTCStateLawChart.pdf
9. Vorhaus D (2011) Updating the DTC Debate: Trial by Press Release, More FDA Letters, the Problem of Pleiotrophy and New RUO Guidance, http://www.genomicslawreport.com/index.php/2011/06/04updating-the-dtc-debate- trial-by-press-release-more-fda-letters-and-the-problem-of-pleiotrophy/
10. Department of Health and Human Services (2011) Summary from the Molecular, Clinical Genetics Panel Meeting-March 8 & 9, 2011. http://www.genomicslawreport.com/wp-content/uploads/2011/03/FDA-DTC-Advisory- Panel-Meeting-Summary.pdf
11. Petersen A, Davis M, Fraser S, Lindsay J (2010) Healthy living and citizenship: an overview. Critical Public Health 20: 391-400
12. Borry PB, Cornel MC, Howard HC (2010) Where are you going, where have you been: a recent history of the direct-to-consumer genetic testing market. J Commun Genet 1: 101-106
13. Gilbody S, Wilson P, Watt I (2005) Benefits and harms of direct to consumer advertising: a systematic review. Qual Saf Health Care 14: 246-250
14. Morgan S, Mintzes B, Barer M (2003) The economics of direct-to-consumer advertising of prescription-only drugs: prescribed to improve consumer welfare? J Health Serv Res Policy 8: 237-244
15. Robinson AR, Hohmann KB, Rifkin JI, Topp D, Gilroy CM, Pickard JA, Anderson RJ (2004) Direct-to-consumer pharmaceutical advertising: physician and public opinion and potential effects on the physician-patient relationship. Arch Intern Med 164: 427-432
16. Weissman JS, Blumenthal D, Silk AJ, Newman M, Zapert K, Leitman R, Feibelmann S (2004) Physicians report on patient encounters involving direct-to-consumer advertising. Health Aff (Millwood) Suppl: 219-233
17. Wicklund CA, O'Neill SM, Hayes MG, Kaushik PM (2011) The attitudes and opinions of genetic researchers and clinicians towards the regulation of direct-to-consumer genetic testing. American Society of Human Genetics/ICHG 2011, Montreal, Canada
18. American Medical Association (2011) AMA Letter to the FDA Regarding Molecular and Clinical Genetics Panel of Medical Devices Advisory Committee. Chicago, Illinois, USA: American Medical Association
19. MacArthur D (2011) American Medical Association: You Can't Look At Your Genome Without Our Supervision. http://www.wired.com/wiredscience/2011/02/ american-medical-association-you-cant-look-at-your-genome-without-our- supervision
20. Kaufman DJ, Bollinger JM, Dvoskin RL, Scott JA (2012) Risky business: risk perception and the use of medical services among customers of DTC personal genetic testing. J Genet Couns 21: 413-422
21. Clarke A, Thirlaway K (2011) 'Genomic counseling'? Genetic counseling in the genomic era. Genome Med 3: 7
22. Cooksey JA, Forte G, Flanagan PA, Benkendorf J, Blitzer MG (2006) The medical genetics workforce: an analysis of clinical geneticist subgroups. Genet Med 8: 603-614
23. Magnus D, Cho MK, Cook-Deegan R (2009) Direct-to-consumer genetic tests: beyond medical regulation? Genome Med 1: 17